NanoPET Pharma

NanoPET Pharma is a Berlin-based diagnostic imaging company with a dual focus on preclinical research tools and clinical medical devices. Established in 2007, it has built a portfolio of innovative imaging agents under the Viscover brand for the preclinical market and commercializes devices for rheumatology diagnostics through its Xiralite subsidiary. The company acts as a B2B provider, leveraging its expertise in R&D, production, and marketing to support pharmaceutical development and improve patient care. Its strategy bridges the gap between early-stage research and clinical application in the diagnostic imaging sector.

Platform for developing diagnostic imaging contrast agents for preclinical research (MRI, CT, ultrasound, optical) and clinical medical devices for rheumatology diagnostics.

In preclinical imaging, NanoPET competes with large life science tools companies (e.g., PerkinElmer, Revvity) and specialized contrast agent developers. In rheumatology diagnostics, it faces competition from established medical device firms and other point-of-care diagnostic solutions.